Literature DB >> 16921506

Quantitative multi-gene expression profiling of primary prostate cancer.

Uta Schmidt1, Susanne Fuessel, Rainer Koch, Gustavo B Baretton, Andrea Lohse, Silke Tomasetti, Susanne Unversucht, Michael Froehner, Manfred P Wirth, Axel Meye.   

Abstract

BACKGROUND: This study describes the evaluation of the expression patterns of prostate-related transcripts in 106 matched prostate tissues from prostatectomies as predictors for prostate cancer (PCa).
METHODS: Quantitative PCR (QPCR) assays with site-specific hybridization probes were established for four housekeeping genes (GAPDH, HPRT, PBGD, TBP) and nine prostate-related genes (AibZIP, D-GPCR, EZH2, PCA3, PDEF, prostein, PSA, PSCA, TRPM8).
RESULTS: The relative mRNA expression levels of AibZIP, D-GPCR, EZH2, PCA3, PDEF, PSA, TRPM8 (all P < 0.001) and prostein (P = 0.019) normalized to the TBP reference gene were significantly higher in malignant compared to non-malignant prostate tissues. Employing receiver-operating characteristic (ROC) analyses, PCA3 was the best single tumor marker with the highest area-under-the-curve (AUC = 0.85). A multivariate logit model for the predictability of the tumor was developed, which employed the relative expression levels of EZH2, PCA3, prostein, and TRPM8 and yielded an AUC of 0.90.
CONCLUSIONS: The transcript marker PCA3 is a powerful predictor of primary PCa but the inclusion of EZH2, prostein, and TRPM8 adds even more to the diagnostic power. The finding of a significantly higher mRNA expression of three different genes (prostein, PSA, TRPM8) in organ-confined tumors compared to non-organ-confined tumors as well as the multi-marker PCa prediction model developed in the retrospective model system on prostatectomies could be of clinical importance for diagnostic purposes, and should be verified in diagnostic biopsies. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16921506     DOI: 10.1002/pros.20490

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  43 in total

Review 1.  Calcium wave signaling in cancer cells.

Authors:  Jai Parkash; Kamlesh Asotra
Journal:  Life Sci       Date:  2010-09-25       Impact factor: 5.037

2.  [Comparative evaluation of expression patterns of established and new prostate carcinoma associated genes with reference to suitability for molecular biologic diagnostic and prognostic factors].

Authors:  S Füssel; S Unversucht; A Meye; D Kunze; G Baretton; M Toma; M Haase; M-O Grimm; J Seifert; C Höfling; R Koch; M P Wirth
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

3.  [Molecular genetic markers for prostate cancer. Evidence in fine needle biopsies for improved confirmation of the diagnosis].

Authors:  S Schneider; S Voigt; S Füssel; A Lohse-Fischer; S Tomasetti; M Haase; R Koch; G B Baretton; M-O Grimm; M Wirth
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639

Review 4.  Calcium channels and pumps in cancer: changes and consequences.

Authors:  Gregory R Monteith; Felicity M Davis; Sarah J Roberts-Thomson
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

5.  Pharmacological and functional properties of TRPM8 channels in prostate tumor cells.

Authors:  Maria Valero; Cruz Morenilla-Palao; Carlos Belmonte; Felix Viana
Journal:  Pflugers Arch       Date:  2010-11-05       Impact factor: 3.657

6.  Diagnostic accuracy of the RBANS in mild cognitive impairment: limitations on assessing milder impairments.

Authors:  Kevin Duff; Valerie L Hobson; Leigh J Beglinger; Sid E O'Bryant
Journal:  Arch Clin Neuropsychol       Date:  2010-06-21       Impact factor: 2.813

7.  Cloning and Characterization of 3.1kb Promoter Region of the Oct4 Gene from the Fischer 344 Rat.

Authors:  Hong He; Mark McHaney; James Hong; Mark L Weiss
Journal:  Open Stem Cell J       Date:  2009-01-01

8.  MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.

Authors:  Kati Erdmann; Knut Kaulke; Christiane Rieger; Karsten Salomo; Manfred P Wirth; Susanne Fuessel
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-25       Impact factor: 4.553

9.  Novel biomarkers for prostate cancer including noncoding transcripts.

Authors:  Tammy L Romanuik; Takeshi Ueda; Nhu Le; Simon Haile; Theresa M K Yong; Thomas Thomson; Robert L Vessella; Marianne D Sadar
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

10.  DKC1 overexpression associated with prostate cancer progression.

Authors:  P Sieron; C Hader; J Hatina; R Engers; A Wlazlinski; M Müller; W A Schulz
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.